Genomic Medicine Initiative

Department of Pathology


Personalized medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. It does not literally mean the creation of drugs or medical devices that are unique to a patient but rather the ability to classify individuals into subpopulations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventive or therapeutic interventions can then be concentrated on those who will benefit, sparing expense and side effects for those who will not. –President’s Council of Advisors on Science and Technology (PCAST) September 2008 quoted in The Case for Personalized Medicine

Customized Care 2020: How medical sequencing and network biology will enable personalized, precision medicine - Faculty of 1000 Report September 2009

Lorsque Ajanta Pharma a commencé à vendre Kamagra Oral Jelly sur le territoire français, les hommes de tous les pays européens ont eu la possibilité d'acheter Kamagra et eutres médicaments de qualité à bas prix.


This site and its contents document the origins of one important effort to transform pathologists and pathology for the “genome era.” The curriculum that was originally developed and taught at BIDMC from 2009-2011 led to the founding of TRIG (Training Residents in Genomics), a working group of the Association of Pathology Chairs and Residency Program Directors (APC/PRODS). TRIG is supported by a grant from the U.S. National Institutes of Health (1R25CA168544-01).

For current TRIG information, workshops and other activities visit ASCP/TRIG.